Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA142025
Max Phase: Preclinical
Molecular Formula: C9H7NO5S
Molecular Weight: 241.22
Molecule Type: Small molecule
Associated Items:
ID: ALA142025
Max Phase: Preclinical
Molecular Formula: C9H7NO5S
Molecular Weight: 241.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS(=O)(=O)ON1C(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C9H7NO5S/c1-16(13,14)15-10-8(11)6-4-2-3-5-7(6)9(10)12/h2-5H,1H3
Standard InChI Key: MZVIAOIHWLOXPX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 241.22 | Molecular Weight (Monoisotopic): 241.0045 | AlogP: 0.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.75 | Molecular Species: | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.33 | CX LogD: 0.33 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.69 | Np Likeness Score: -0.50 |
1. Kerrigan JE, Shirley JJ. (1996) 2-[(Alkylsulfonyl)oxy]-6-substituted-1H-isoindole-1,3(2H)-dione mechanism-based inhibitors of human leukocyte elastase, 6 (4): [10.1016/0960-894X(96)00038-8] |
2. Chan CL, Lien EJ, Tokes ZA.. (1987) Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of 2-hydroxy-1H-isoindolediones as new cytostatic agents., 30 (3): [PMID:3820223] [10.1021/jm00386a012] |
3. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |
Source(1):